IMRX
IMRX
NASDAQ · Biotechnology

Immuneering Corp - Class A

Small-Cap Stocks Stocks Under $10 Biotech Stocks Healthcare Stocks
$5.22
+0.00 (+0.00%)
As of May 10, 10:28 PM ET ·
Analyst Consensus
Strong Buy
12
Analysts
Moderate
Coverage
Buy 11 92%
Hold 1 8%
Sell 0 0%
Price Target
Analyst Price Target -32.2% upside
Low Target $2.50
Average Target $3.54
High Target $3.55
Current Price $5.22
Current
$5.22
Target
$3.54
$2.50 $3.54 avg $3.55
Scenario Analysis
Bear Case
$2.50
-52.1%
Low target
Base Case
$3.54
-32.2%
Avg target
Bull Case
$3.55
+-32.0%
High target
Risk/Reward
0.6x
Unfavorable
Price in Context
52-Week High
$10.08
-48.2% from high
52-Week Low
$1.10
+374.5% from low
Target vs 52W High
$3.54
-64.9% vs high
Next Earnings Report
May 12, 2026
Today
EPS Est: $-0.26
Earnings in today. Analyst targets may shift significantly after the report.
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Strong Buy 40 75% $257.58 +27.8%
AMGN
Amgen Inc
 Hold 44 48% $190.87 -42.5%
GILD
Gilead Sciences Inc
 Strong Buy 39 79% $362.68 +176.2%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 39 79% $438.34 +2.0%
REGN
Regeneron Pharmaceuticals
 Strong Buy 38 79% $76.80 -89.3%
ALNY
Alnylam Pharmaceuticals Inc
 Strong Buy 36 75% $102.31 -65.3%
RVMD
Revolution Medicines Inc
 Strong Buy 27 96% $114.11 -19.5%
INSM
Insmed Inc
 Strong Buy 28 96% $143.40 +41.5%